LYMPHOPENIA / IMMUNOPARALYSIS IN CRITICALLY ILL ADULTS

Clinical trials for LYMPHOPENIA / IMMUNOPARALYSIS IN CRITICALLY ILL ADULTS explained in plain language.

Never miss a new study

Get alerted when new LYMPHOPENIA / IMMUNOPARALYSIS IN CRITICALLY ILL ADULTS trials appear

Sign up with your email to follow new studies for LYMPHOPENIA / IMMUNOPARALYSIS IN CRITICALLY ILL ADULTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New immune combo aims to rescue ICU patients from severe pneumonia

Disease control Not yet recruiting

This early study tests whether adding two immune-boosting treatments—nogapendekin alfa inbakicept (injections) and donor immune cells (iNKT cells)—to standard care can help critically ill adults with severe pneumonia recover. About 20 ICU patients will receive the therapy and be …

Matched conditions: LYMPHOPENIA / IMMUNOPARALYSIS IN CRITICALLY ILL ADULTS

Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control

Last updated Apr 26, 2026 20:03 UTC

LYMPHOPENIA / IMMUNOPARALYSIS IN CRITICALLY ILL ADULTS

Get alerted when new LYMPHOPENIA / IMMUNOPARALYSIS IN CRITICALLY ILL ADULTS trials appear

New immune combo aims to rescue ICU patients from severe pneumonia